v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 6,298 $ 7,676
Investments 959 1,056
Accounts receivable, net 30,800 28,768
Inventories 5,847 7,338
Other current assets 3,087 2,976
Total current assets 46,991 47,814
Long-term investments 19,037 18,471
Reinsurance recoverables 3,982 4,103
Property and equipment 3,736 3,651
Goodwill 45,534 44,924
Other intangible assets 26,931 28,560
Other assets 3,323 2,885
Separate account assets 7,548 7,511
TOTAL ASSETS 157,082 157,919
Liabilities    
Current insurance and contractholder liabilities 6,689 5,710
Pharmacy and other service costs payable 26,225 30,333
Accounts payable 10,409 10,659
Accrued expenses and other liabilities 9,447 9,048
Short-term debt 2,792 592
Total current liabilities 55,562 56,342
Non-current insurance and contractholder liabilities 9,633 9,938
Deferred tax liabilities, net 6,731 7,145
Other non-current liabilities 5,612 4,238
Long-term debt 29,086 30,871
Separate account liabilities 7,548 7,511
TOTAL LIABILITIES 114,172 116,045
Contingencies — Note 14
Shareholders' equity    
Common stock [1] 4 4
Additional paid-in capital 32,092 31,790
Accumulated other comprehensive loss (4,361) (2,806)
Retained earnings 50,355 47,865
Less: Treasury stock, at cost (35,470) (35,140)
TOTAL SHAREHOLDERS' EQUITY 42,620 41,713
Noncontrolling interests 290 161
Total equity 42,910 41,874
Total liabilities and equity $ 157,082 $ 157,919
[1] Par value per share, $0.01; shares issued, 406 million as of June 30, 2026 and 405 million as of December 31, 2025; authorized shares, 600 million.